BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21033222)

  • 1. Mast cells count and serum cytokine levels in patients with irritable bowel syndrome.
    Goral V; Kucukoner M; Buyukbayram H
    Hepatogastroenterology; 2010; 57(101):751-4. PubMed ID: 21033222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors.
    Lee KJ; Kim YB; Kim JH; Kwon HC; Kim DK; Cho SW
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1689-94. PubMed ID: 19120860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal mast cell counts correlate with visceral hypersensitivity in patients with diarrhea predominant irritable bowel syndrome.
    Park JH; Rhee PL; Kim HS; Lee JH; Kim YH; Kim JJ; Rhee JC
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):71-8. PubMed ID: 16706815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immune cell numbers and visceral sensitivity in patients with irritable bowel syndrome: is there any relationship?
    Braak B; Klooker TK; Wouters MM; Welting O; van der Loos CM; Stanisor OI; van Diest S; van den Wijngaard RM; Boeckxstaens GE
    Am J Gastroenterol; 2012 May; 107(5):715-26. PubMed ID: 22488080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome.
    Cremon C; Carini G; Wang B; Vasina V; Cogliandro RF; De Giorgio R; Stanghellini V; Grundy D; Tonini M; De Ponti F; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2011 Jul; 106(7):1290-8. PubMed ID: 21427712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mast cells and cellularity of the colonic mucosa correlated with fatigue and depression in irritable bowel syndrome.
    Piche T; Saint-Paul MC; Dainese R; Marine-Barjoan E; Iannelli A; Montoya ML; Peyron JF; Czerucka D; Cherikh F; Filippi J; Tran A; Hébuterne X
    Gut; 2008 Apr; 57(4):468-73. PubMed ID: 18194987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucosal mast cells in irritable bowel syndrome and inflammatory bowel disease.
    Tunc B; Filik L; Altintaş E; Turhan N; Ulker A; Dağli U
    Acta Medica (Hradec Kralove); 2005; 48(3-4):163-4. PubMed ID: 16640031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell number, substance P and vasoactive intestinal peptide in irritable bowel syndrome with diarrhea.
    Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Sim J; Jang KS
    Scand J Gastroenterol; 2014 Jan; 49(1):43-51. PubMed ID: 24256141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.
    Guilarte M; Santos J; de Torres I; Alonso C; Vicario M; Ramos L; Martínez C; Casellas F; Saperas E; Malagelada JR
    Gut; 2007 Feb; 56(2):203-9. PubMed ID: 17005763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome.
    Klooker TK; Braak B; Koopman KE; Welting O; Wouters MM; van der Heide S; Schemann M; Bischoff SC; van den Wijngaard RM; Boeckxstaens GE
    Gut; 2010 Sep; 59(9):1213-21. PubMed ID: 20650926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
    Coëffier M; Gloro R; Boukhettala N; Aziz M; Lecleire S; Vandaele N; Antonietti M; Savoye G; Bôle-Feysot C; Déchelotte P; Reimund JM; Ducrotté P
    Am J Gastroenterol; 2010 May; 105(5):1181-8. PubMed ID: 19997094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome.
    Barbara G; Wang B; Stanghellini V; de Giorgio R; Cremon C; Di Nardo G; Trevisani M; Campi B; Geppetti P; Tonini M; Bunnett NW; Grundy D; Corinaldesi R
    Gastroenterology; 2007 Jan; 132(1):26-37. PubMed ID: 17241857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell activation in patients with irritable bowel syndrome.
    Ohman L; Isaksson S; Lindmark AC; Posserud I; Stotzer PO; Strid H; Sjövall H; Simrén M
    Am J Gastroenterol; 2009 May; 104(5):1205-12. PubMed ID: 19367268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in tight junction of intestinal mucosa in patients with irritable bowel syndrome: a study with tracing electron microscope].
    Kong WM; Gong J; Dong L; Chen MX
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1167-70, 1172. PubMed ID: 17715017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of mucosal mast cells in visceral hypersensitivity in a rat model of irritable bowel syndrome.
    La JH; Kim TW; Sung TS; Kim HJ; Kim JY; Yang IS
    J Vet Sci; 2004 Dec; 5(4):319-24. PubMed ID: 15613815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes of tight junction claudin-1,-3,-4 protein expression in the intestinal mucosa in patients with irritable bowel syndrome].
    Kong WM; Gong J; Dong L; Xu JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Sep; 27(9):1345-7. PubMed ID: 17884774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.
    Cremon C; Gargano L; Morselli-Labate AM; Santini D; Cogliandro RF; De Giorgio R; Stanghellini V; Corinaldesi R; Barbara G
    Am J Gastroenterol; 2009 Feb; 104(2):392-400. PubMed ID: 19174797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome.
    Buhner S; Li Q; Vignali S; Barbara G; De Giorgio R; Stanghellini V; Cremon C; Zeller F; Langer R; Daniel H; Michel K; Schemann M
    Gastroenterology; 2009 Oct; 137(4):1425-34. PubMed ID: 19596012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker?
    Dinan TG; Quigley EM; Ahmed SM; Scully P; O'Brien S; O'Mahony L; O'Mahony S; Shanahan F; Keeling PW
    Gastroenterology; 2006 Feb; 130(2):304-11. PubMed ID: 16472586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.